Press Releases
The RCI becomes a Leibniz Institute in Regensburg
(No. 256) Promotion to the elite league of immunology: The Regensburg Center for Interventional Immunology (RCI) was admitted to the Leibniz Association at the beginning of this year. This gives the cathedral city a highly competent non-university research institute that deals with the fundamentals for the development of new immunotherapies to fight cancer, chronic inflammation, and autoimmune diseases.
read on
Lifespin GmbH from Regensburg secures bridge financing
(No. 255) Lifespin GmbH in BioPark Regensburg has successfully concluded bridge financing to a total of € 2.5 million. The diagnostic data company is working successfully on an AI-based health platform that can measure important metabolic parameters in patients and expects to start series A in the funding cycle in 2022.
read on
Healing with resistance-breaking molecules from Regensburg
(No. 254) Lysando AG in BioPark Regensburg and AiCuris AG, a spin-off from Bayer AG, have started a new joint project for the treatment of chronic wounds, such as those of the diabetic foot. With a completely new class of molecules, antibiotic resistance is to be broken through and new treatment options made possible.
read on
Innovative therapeutic approach with nanocarriers
(No. 253) BioPark Regensburg GmbH, a company of the City of Regensburg, and the patent law firm Dehmel & Bettenhausen based there have awarded this year's innovation prize for an outstanding doctoral thesis at the University of Regensburg. The thesis describes a novel strategy for the treatment of diabetic nephropathy with the aid of nanocarriers.
read on
Regensburg clusters bundle AI expertise in the goAIR project
(No. 252) Four industry clusters are located in both the technology and start-up centers of the City of Regensburg-BioPark and TechBase, which for the first time have launched a cross-network initiative in the field of artificial intelligence (AI). The cross-cluster project, in which the Bioregion Regensburg is involved, was convincing at the federal level and is being funded for 1 year with funds from the “go-cluster” program.
read onARCHIVE
